Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Proceedings (Baylor University. Medical Center)
|
April 3, 2008
The ectopic adrenocorticotropic hormone syndrome in carcinoid tumors
Poorya Fazel, Prasanthi Ganesa, Robert G Mennel, et al.
Proceedings (Baylor University. Medical Center)
|
July 2, 2016
Mammary-type myofibroblastoma with the nephrotic syndrome
Gates B Colbert, Preksha Vankawala, Michael B Kuperman, et al.
Proceedings (Baylor University. Medical Center)
|
April 22, 2020
Isolated adrenocorticotrophic hormone deficiency in a patient treated with checkpoint inhibitor therapy
Azaan Ramani, Taylor Maloney, Brooke Mills, et al.
Proceedings (Baylor University. Medical Center)
|
January 27, 2009
Primary effusion lymphoma diagnosed by pericardiocentesis
Michael C Nemunaitis, Jeffrey M Schussler, S Michelle Shiller, et al.
Clinical Breast Cancer
|
July 9, 2005
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer
Joyce A O'Shaughnessy, Romnee S Clark, Joanne L Blum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 27, 2015
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer
Minal Barve, Zhaohui Wang, Padmasini Kumar, et al.
BMC Cancer
|
January 7, 2017
Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies
Leah Zhrebker, Irene Cherni, Lara M Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2004
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer
Alan M Keller, Robert G Mennel, Vassilis A Georgoulias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop, Nofisat Ismaila, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Proceedings (Baylor University. Medical Center)
|
April 3, 2008
The ectopic adrenocorticotropic hormone syndrome in carcinoid tumors
Poorya Fazel, Prasanthi Ganesa, Robert G Mennel, et al.
Proceedings (Baylor University. Medical Center)
|
July 2, 2016
Mammary-type myofibroblastoma with the nephrotic syndrome
Gates B Colbert, Preksha Vankawala, Michael B Kuperman, et al.
Proceedings (Baylor University. Medical Center)
|
April 22, 2020
Isolated adrenocorticotrophic hormone deficiency in a patient treated with checkpoint inhibitor therapy
Azaan Ramani, Taylor Maloney, Brooke Mills, et al.
Proceedings (Baylor University. Medical Center)
|
January 27, 2009
Primary effusion lymphoma diagnosed by pericardiocentesis
Michael C Nemunaitis, Jeffrey M Schussler, S Michelle Shiller, et al.
Clinical Breast Cancer
|
July 9, 2005
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer
Joyce A O'Shaughnessy, Romnee S Clark, Joanne L Blum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 27, 2015
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer
Minal Barve, Zhaohui Wang, Padmasini Kumar, et al.
BMC Cancer
|
January 7, 2017
Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies
Leah Zhrebker, Irene Cherni, Lara M Gross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2004
Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer
Alan M Keller, Robert G Mennel, Vassilis A Georgoulias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
Ian Krop, Nofisat Ismaila, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Lyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Page
of 2